Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,775.00p
   
  • Change Today:
      50.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 8,653
  • Market Cap: £144.99m

Latest ShareCast News

Revenue rises, profit falls for Bioventix

By Josh White

Date: Monday 31 Mar 2025

(Sharecast News) - Bioventix reported a marginal rise in revenue for the six months ended 31 December on Monday, with profit before tax dipping slightly due to higher research and development expenditure.

Director dealings: Bioventix CFO raises stake

By Iain Gilbert

Date: Thursday 31 Oct 2024

(Sharecast News) - Bioventix revealed on Thursday that chief financial officer Bruce Hiscock had acquired 333 ordinary shares in the London-listed antibodies development and supply company.

BioVentix reports year of growth, warns of geopolitical risks

By Josh White

Date: Monday 28 Oct 2024

(Sharecast News) - BioVentix, a UK-based developer of high-affinity monoclonal antibodies for clinical diagnostics, reported a 6% improvement in full-year revenue on Monday, to £13.6m, up from £12.82m in the prior year.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,775.00p
Change Today 50.00p
% Change 1.83 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 8,653
Shares Issued 5.22m
Market Cap £144.99m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average17.77% below the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Price Trend
65.33% below the market average65.33% below the market average65.33% below the market average65.33% below the market average65.33% below the market average
21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average21.74% below the sector average
Income
44.75% above the market average44.75% above the market average44.75% above the market average44.75% above the market average44.75% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
9.36% below the market average9.36% below the market average9.36% below the market average9.36% below the market average9.36% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 11-Jul-2025

Time Volume / Share Price
16:29 100 @ 2,774.00p
15:05 1,210 @ 2,752.50p
15:05 1,210 @ 2,750.00p
14:23 5 @ 2,750.00p
13:04 1,000 @ 2,751.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page